Last reviewed · How we verify
Clomid, Respatio and Ethinyl estradiol — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Clomid, Respatio and Ethinyl estradiol (Clomid, Respatio and Ethinyl estradiol) — Nesreen Abdel Fattah Abdullah Shehata.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Clomid, Respatio and Ethinyl estradiol TARGET | Clomid, Respatio and Ethinyl estradiol | Nesreen Abdel Fattah Abdullah Shehata | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Clomid, Respatio and Ethinyl estradiol CI watch — RSS
- Clomid, Respatio and Ethinyl estradiol CI watch — Atom
- Clomid, Respatio and Ethinyl estradiol CI watch — JSON
- Clomid, Respatio and Ethinyl estradiol alone — RSS
Cite this brief
Drug Landscape (2026). Clomid, Respatio and Ethinyl estradiol — Competitive Intelligence Brief. https://druglandscape.com/ci/clomid-respatio-and-ethinyl-estradiol. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab